vTv Therapeutics Inc <VTVT.OQ> expected to post a loss of 81 cents a share - Earnings Preview

• vTv Therapeutics Inc VTVT.OQ VTVT.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025

• ​LSEG's mean analyst estimate for vTv Therapeutics Inc is for a loss of 81 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for vTv Therapeutics Inc is $35.50​, above​ its last closing price of $22.46. ​​​

This summary was machine generated May 5 at 11:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)